Treatment of Concomitant Intra-abdominal Malignancy and Abdominal Aortic Aneurysm.

Xu ZHANG; Fang da LI; Wei WANG; Lei JI; Jin Rui REN; Yue Xin CHEN; Wei YE; Bao LIU; Chang Wei LIU; Yue Hong ZHENG

Return

Treatment of Concomitant Intra-abdominal Malignancy and Abdominal Aortic Aneurysm.

Author: Xu ZHANG ¹ ; Fang da LI ¹ ; Wei WANG ¹ ; Lei JI ¹ ; Jin Rui REN ¹ ; Yue Xin CHEN ¹ ; Wei YE ¹ ; Bao LIU ¹ ; Chang Wei LIU ¹ ; Yue Hong ZHENG ¹
Author Information

1. Department of Vascular Surgery,PUMC Hospital,CAMS and PUMC,Beijing 100730,China.
Publication Type:Journal Article
Keywords: abdominal aortic aneurysm; concomitant intra-abdominal malignancy; endovascular abdominal aortic aneurysm repair
MeSH: Abdominal Neoplasms/surgery*; Aortic Aneurysm, Abdominal/surgery*; Blood Vessel Prosthesis Implantation; Endovascular Procedures; Humans; Retrospective Studies; Risk Factors; Treatment Outcome
From: Acta Academiae Medicinae Sinicae 2021;43(1):37-41
CountryChina
Language:Chinese
Abstract: Objective To explore the outcomes in patients who receive the endovascular abdominal aortic aneurysm repair(EVAR)and have concomitant intra-abdominal malignancy.Methods Between January 2014 and December 2019,all the patients who underwent surgery for malignancy and/or EVAR were retrospectively reviewed.Results Twenty-eight abdominal aortic aneurysm(AAA)patients with concomitant intra-abdominal malignancy were included.The patients were treated by two-stage operation and the priority was given for EVAR in 21 patients.There was no perioperative death or major complications.In the follow-up,one patient developed graft thrombosis and one had type Ⅱ endoleak.There was no AAA-associated death.Conclusions It is preferred that EVAR should come first followed by operation for malignancy.Details of treatment strategy still need further investigation.